Concentrated autologous bone marrow mononuclear cells (ABM MNC) contain potentially therapeutic cell factors and past studies support therapeutic benefit to pa…

Ischemic Heart Failure

~Estimated

~$10 – $1,050

Actual pay is set by the research site.

BioCardia, Inc.NCT06258447

Phase 1

A Phase I/IIa, Open-Label, Dose Escalation Study to Evaluate the Safety and Tolerability of HiCM-188, an Allogeneic iPSC-derived Cardiomyocyte Therapy, in Adult Patients With Advanced Heart Failure

This clinical study will evaluate the safety and tolerability of HiCM-188, an investigational allogeneic induced pluripotent stem cell (iPSC)-derived cardiomyo…

Advanced Heart FailureIschemic Heart Failure

~Estimated

~$150 – $4,200

Actual pay is set by the research site.

HELP Therapeutics Co., Ltd.NCT07646210